Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-10-14 | New | $2,990,496 | $2,990,496 | Equity Only | 06b | SEC link |
| 2025-06-11 | New | $694,998 | $694,998 | Equity Only | 06b | SEC link |
| 2025-03-04 | New | $4,143,949 | $4,143,949 | Equity Only | 06b | SEC link |
| 2024-11-12 | New | $2,439,260 | $2,439,260 | Equity Only | 06b | SEC link |
| 2024-03-21 | New | $2,920,692 | $2,920,692 | Equity Only | 06b | SEC link |
| 2023-11-29 | New | $4,859,092 | $4,859,092 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Steven Chaouki | Director |
| Sergei Gryaznov | Executive |
| Ramiro Guerrero | Director |
| Jeffrey Himmelreich | Executive |
| Ngar Yee Louie | Director |
| Ngar Yee Louie | Director |
| Cristian Luput | Director |
| Stan Smith | Director |
| Jean Manasse Theagene | Director |
| Vlad Vitoc | Director, Executive |
| Louie Ngar Yee | Director |